New strategies for cartilage regeneration exploiting selected glycosaminoglycans to enhance cell fate determination

Biochemical Society Transactions

Volumn 42, Issue 3, 2014, Pages 703-709

  Ayerst, Bethanie I ^a,b,c   Day, Anthony J ^a   Nurcombe, Victor ^b   Cool, Simon M ^b   Merry, Catherine L R ^c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Cartilage; Cell fate determination; Glycosaminoglycan (GAG); Growth factor (GF); Heparan sulfate (HS); Tissue engineering

Indexed keywords

BIOMATERIAL; GLYCOSAMINOGLYCAN; GROWTH FACTOR;

ARTICLE; CARTILAGE; CELL DIFFERENTIATION; CELL FATE; CHONDROGENESIS; CONFORMATION; EXTRACELLULAR MATRIX; HUMAN; HYDROGEL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; STRUCTURE ACTIVITY RELATION; SULFATION; TISSUE ENGINEERING; TISSUE REGENERATION; CELL LINEAGE; CYTOLOGY; METABOLISM; PHYSIOLOGY; REGENERATION;

CARTILAGE; CELL LINEAGE; GLYCOSAMINOGLYCANS; HUMANS; REGENERATION;

EID: 84901501284     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20140031     Document Type: Article

References (58)

1. Hardingham, T.E. (2010) Fell-Muir Lecture: Cartilage 2010 -the known unknowns. Int. J. Exp. Pathol. 91, 203-209 CrossRef PubMed
2. Goldring, M.B. (2000) The role of the chondrocyte in osteoarthritis. Arthritis Rheum. 43, 1916-1926 CrossRef PubMed
3. Schinagl, R.M., Gurkis, D., Chen, A.C. and Sah, R.L. (1997) Depth-dependent confined compression modulus of full-thickness bovine articular cartilage. J. Orthop. Res. 15, 499-506 CrossRef PubMed
4. Lawrence, R.C., Felson, D.T., Helmick, C.G., Arnold, L.M., Choi, H., Deyo, R.A., Gabriel, S., Hirsch, R., Hochberg, M.C., Hunder, G.G. et al. (2008) Estimates of the prevelance of arthritis and other rheumatic conditions in the United States, Part II. Arthritis Rheum. 58, 26-35 CrossRef PubMed
5. Carr, A.J., Robertsson, O., Graves, S., Price, A.J., Arden, N.K., Judge, A. and Beard, D.J. (2012) Knee replacement. Lancet 379, 1331-1340 CrossRef PubMed
6. Harris, J.D., Siston, R.A., Pan, X. and Flanigan, D.C. (2010) Autologous chondrocyte implantation: a systematic review. J. Bone Joint Surg. Am. 92, 2220-2233 PubMed
7. Wood, J.J., Malek, M.A., Frassica, F.J., Polder, J.A., Mohan, A.K., Bloom, E.T., Braun, M.M. and Coté, T.R. (2006) Autologous cultured chondrocytes: adverse events reported to the United States food and drug administration. J. Bone Joint Surg. Am. 88, 503-507 CrossRef PubMed
8. Tew, S.R., Murdoch, A.D., Rauchenberg, R.P. and Hardingham, T.E. (2008) Cellular methods in cartilage research: primary human chondrocytes in culture and chondrogenesis in human bone marrow stem cells. Methods 45, 2-9 CrossRef PubMed
9. Martin, J.A. and Buckwalter, J.A. (2003) The role of chondrocyte senescence in the pathogenesis of osteoarthritis and in limiting cartilage repair. J. Bone Joint Surg. Am. 85, 106-110 PubMed
10. Kock, L., van Donkelaar, C.C. and Ito, K. (2012) Tissue engineering of functional articular cartilage: the current status. Cell Tissue Res. 347, 613-627 CrossRef PubMed
11. Beane, O.S. and Darling, E.M. (2012) Characterization and differentiation of stem cells for cartilage regeneration. Ann. Biomed. Eng. 40, 2079-2097 CrossRef PubMed
12. Polo, J.M., Liu, S., Figueroa, M.E., Kulalert, W., Eminli, S., Tan, K.Y., Apostolou, E., Stadtfeld, M., Li, Y., Shioda, T. et al. (2010) Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat. Biotechnol. 28, 848-855 CrossRef PubMed
13. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz-Gonzalez, X.R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M. et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49 CrossRef PubMed
14. Oh, J.Y., Lee, R.H., Yu, J.M., Ko, J.H., Lee, H.J., Ko, A.Y., Roddy, G.W. and Prockop, D.J. (2012) Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response. Mol. Ther. 20, 2143-2152 CrossRef PubMed
15. Dyer, D.P., Thompson, J.M., Hermant, A., Jowitt, T.A., Handel, T.M., Proudfoot, A.E.I., Day, A.J. and Milner, C.M. (2014) TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8. J. Immunol. 192, 2177-2185 CrossRef PubMed
16. Ando, W., Tateishi, K., Hart, D.A., Katakai, D., Tanaka, Y., Nakata, K., Hashimoto, J., Fujie, H., Shino, K., Yoshikawa, H. and Nakamura, N. (2007) Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. Biomaterials 28, 5462-5470 CrossRef PubMed
17. Murdoch, A.D., Grady, L.M., Ablett, M.P., Katopodi, T., Meadows, R.S. and Hardingham, T.E. (2007) Chondrogenic differentiation of human bone marrow stem cells in Transwell cultures: generation of scaffold-free cartilage. Stem Cells 25, 2786-2796 CrossRef PubMed
18. Pampaloni, F., Reynaud, E.G. and Steizer, E.H.K. (2007) The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell Biol. 8, 839-845 CrossRef PubMed
19. Cao, Y., Li, D., Shang, C., Yang, S.-T., Wang, J. and Wang, X. (2010) Three-dimensional culture of human mesenchymal stem cells in a polyethylene terephthalate matrix. Biomed. Mat. 5, 1-7
20. Liu, X., Holzwarth, M. and Ma, P.X. (2012) Functionalized synthetic biodegradable polymer scaffolds for tissue engineering. Macromol. Biosci. 12, 911-919 CrossRef PubMed
21. Hutmacher, D.W. and Cool, S. (2007) Concepts of scaffold-based tissue engineering: the rationale to use solid free-form fabrication techniques. J. Cell. Mol. Med. 11, 654-669 CrossRef PubMed
22. Franke, T.F., Yang, S.-I., Chan, T.O., Datta, K., Kazlauskas, A., Morrison, D.K., Kaplan, D.R. and Tsichlis, P.N. (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81, 727-736 CrossRef PubMed
23. Robinson, D.E., Buttle, D.J., Short, R.D., McArthur, S.L., Steele, D.A. and Whittle, J.D. (2012) Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions. Biomaterials 33, 1007-1016 CrossRef PubMed
24. Kim, S.-H., Turnbull, J. and Guimond, S. (2011) Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J. Endocrinol. 209, 139-151 CrossRef PubMed
25. Vincent, T.L., McLean, C.J., Full, L.E., Peston, D. and Saklatvala, J. (2007) FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage, where it acts as a chondrocyte mechanotransducer. Osteoarthritis Cartilage 7, 752-763 CrossRef
26. Chia, S.L., Sawaji, Y., Burleigh, A., McLean, C., Inglis, J., Saklatvala, J. and Vincent, T. (2009) Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum. 60, 2019-2027 CrossRef PubMed
27. Melrose, J., Isaacs, M.D., Smith, S.M., Hughes, C.E., Little, C.B., Caterson, B. and Hayes, A.J. (2012) Chondroitin sulphate and heparan sulphate sulphation motifs and their proteoglycans are involved in articular cartilage formation during human foetal knee joint development. Histochem. Cell Biol. 138, 461-475 CrossRef PubMed
28. Mackay, A.M., Beck, S.C., Murphy, J.M., Barry, F.P., Chichester, C.O. and Pittenger, M.F. (1998) Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng. 4, 415-428 CrossRef PubMed
29. Lyon, M., Rushton, G. and Gallagher, J.T. (1997) The interaction of the transforming growth factor-βs with heparin/heperan sulfate is isoform-specific. J. Biol. Chem. 18, 18000-18006 CrossRef
30. Takeuchi, Y., Kodama, Y. and Matsumoto, T. (1994) Bone matrix decorin binds transforming growth factor-β and enhances bioactivity. J. Biol. Chem. 23, 32634-32638
31. Majumdar, M.K., Wang, E. and Morris, E.A. (2001) BMP-2 and BMP-9 promote chondrogenic differentiation of human multipotential mesenchymal cells and overcome the inhibitory effect of IL-1. J. Cell. Physiol. 189, 275-284 CrossRef PubMed
32. Yazaki, Y., Matsunaga, S., Onisi, T., Nagamine, T., Origuchi, N., Yamamoto, T., Ishidou, Y., Imamura, T. and Sakou, T. (1998) Immunohistochemical localization of bone morphogenic proteins and the receptors in epiphyseal growth plate. Anticancer Res. 18, 2339-2344 PubMed
33. Ling, L., Nurcombe, V. and Cool, S.M. (2009) Wnt signaling controls the fate of mesenchymal stem cells. Gene 433, 1-7 CrossRef PubMed
34. Pain-Saunders, S., Viviano, B.L., Zupicich, J., Skarnes, W.C. and Saunders, S. (2000) Glypican-3 controls cellular responses to BMP-4 in limb patterning and skeletal development. Dev. Biol. 225, 179-187 CrossRef PubMed
35. Gomes, Jr, R.R., Farach Carson, M.C. and Carson, D.D. (2003) Perlecan-stimulated nodules undergo chondrogenic maturation in response to rhBMP-2 treatment in vitro. Connect. Tissue Res. 44, 196-201 CrossRef PubMed
36. Murali, S., Rai, B., Dombrowski, C., Lee, J.L.J., Lim, Z.X.H., Bramono, D.S., Ling, L., Bell, T., Hinkley, S., Nathan, S.S. et al. (2013) Affinity-selected heparan sulphate for bone repair. Biomaterials 34, 5594-5605 CrossRef PubMed
37. Coleman, C.M., Vaughan, E.E., Browe, D.C., Mooney, E., Howard, L. and Barry, F. (2013) Growth differentiation factor-5 enhances in vitro mesenchymal stromal cell chondrogenesis and hypertrophy. Stem Cells Dev. 22, 1968-1976 CrossRef PubMed
38. Ghandi, N.S. and Mancera, R.L. (2012) Prediction of heparin binding sites in bone morphogenic proteins (BMPs). Biochim. Biophys. Acta 1824, 1374-1381 CrossRef PubMed
39. Hartman, C. and Tablin, C.J. (2000) Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development 127, 3141-3159 PubMed
40. Boer, J., Siddappa, R., Gaspar, C., Apeldoorn, A., Fodde, R. and Blitterswijk, C. (2004) Wnt signaling inhibits osteogenic differentiation of human mesenchymal stem cells. Bone 34, 818-826 CrossRef PubMed
41. Macri, L., Silverstein, D. and Clark, R.A.F. (2007) Growth factor binding to the pericellular matrix and its importance in tissue engineering. Adv. Drug Deliv. Rev. 59, 1366-1381 CrossRef PubMed
42. Chandran, P.L. and Horkay, F. (2012) Aggrecan, an unusual polyelectrolyte: review of solution behavior and physiological implications. Acta Biomater. 8, 3-12 CrossRef PubMed
43. Knudson, C.B. and Knudson, W. (1993) Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J. 7, 1233-1241 PubMed
44. Baldwin, R.J., ten Dam, G.B., Kuppevelt, T.H., Lacaud, G., Gallagher, J.T., Kouskoff, V. and Merry, C.L.R. (2008) A developmentally regulated heparan sulphate epitope defines a subpopulation with increased blood potential during mesodermal differentiation. Stem Cells 26, 3108-3118 CrossRef PubMed
45. Johnson, C.E., Crawford, B.E., Stavridis, M., ten Dam, G., Wat, A.L., Rushton, G., Ward, C.M., Wilson, V., Kuppevelt, T.H., Esko, J.D. et al. (2007) Essential alterations of heparan sulphate during the differentiation of embryonic stem cells to Sox1-enhanced green fluorescent protein-expressing neural progenitor cells. Stem Cells 25, 1913-1923 CrossRef PubMed
46. Pickford, C.E., Holley, R.J., Rushton, G., Stavridis, M.P., Ward, C.M. and Merry, C.L.R. (2011) Specific glycosaminoglycans modulate neural specification of mouse embryonic stem cells. Stem Cells 29, 629-640 CrossRef PubMed
47. Nguyen, L.H., Kudva, A.K., Guckert, N.L., Linse, K.D. and Roy, K. (2011) Unique biomaterial compositions direct bone marrow stem cells into specific chondrocytic phenotypes corresponding to the various zones of articular cartilage. Biomaterials 32, 1327-1338 CrossRef PubMed
48. Matsiko, A., Levingstone, T.J., O'Brien, F.J. and Gleeson, J.P. (2012) Addition of hyaluronic acid improves cellular infiltration and promotes early-stage chondrogenesis in a collagen-based scaffold for cartilage tissue engineering. J. Mech. Behav. Biomed. Mater. 11, 41-52 CrossRef PubMed
49. Ikeda, Y., Charef, S., Ouidja, M.-O., Barbier-Chassefie re, V., Sineriz, F., Duchesnay, A., Narasimprakash, H., Martelly, I., Kern, P., Barritault, D. et al. (2011) Synthesis and biological activities of a library of glycosaminoglycans mimetic oligosaccharides. Biomaterials 32, 769-776 CrossRef PubMed
50. DeAngelis, P.L. (2012) Glycosaminoglycan polysaccharide biosynthesis and production: today and tomorrow. Appl. Microbiol. Biotechnol. 94, 295-305 CrossRef PubMed
51. Kim, Y.J., Kang, I.K., Huh, M.W. and Yoon, S.C. (2000) Surface characterization and in vitro blood compatibility of poly(ethylene terephthalate) immobilized with insulin and/or heparin using plasma glow discharge. Biomaterials 21, 21-30
52. Payne, C.K., Jones, S.A., Chen, C. and Zhuang, X. (2007) Internalization and trafficking of cell surface proteoglycans and proteoglycan-binding ligands. Traffic 8, 389-401 CrossRef PubMed
53. Mahoney, D.J., Whittel, J.D., Milner, C.M., Clark, S.J., Mulloy, B., Buttle, D.J., Jones, G.C., Day, A.J. and Short, R.D. (2004) A method for the non-covalent immobilization of heparin to surfaces. Anal. Biochem. 330, 123-129 CrossRef PubMed
54. Marson, A., Robinson, D.E., Brookes, P.N., Mulloy, B., Wiles, M., Clark, S.J., Fielder, H.L., Collinson, L.J., Cain, S.A., Kielty, C.M. et al. (2009) Development of a microtiter plate-based glycosaminoglycan array for the investigation of glycosaminoglycan-protein interactions. Glycobiology 19, 1537-1546 CrossRef PubMed
55. Meade, K.A., White, K.J., Pickford, C.E., Holley, R.J., Marson, A., Tillotson, D., van Kuppevelt, T.H., Whittle, J.D., Day, A.J. and Merry, C.L.R. (2013) Immobilization of heparan sulphate on electrospun meshes to support embryonic stem cell culture and differentiation. J. Biol. Chem. 288, 5530-5538 CrossRef PubMed
56. Schwo? rer, R., Zubkova, O.V., Turnball, J.E. and Tyler, P.C. (2013) Synthesis of a targeted library of heparan sulphate hexa-to dodecasaccharides as inhibitors of β-secretase: potential therapeutics for Alzheimer's disease. Chemistry 19, 6817-6823 CrossRef PubMed
57. Place, L.W., Sekyi, M. and Kipper, M.J. (2014) Aggrecanmimetic, glycosaminoglycan-containing nanoparticles for growth factor stabilization and delivery. Biomacromolecules 15, 680-689 CrossRef PubMed
58. Mart́in, P.G., Martinez, A.R., Lara, V.G. and Naveros, B.C. (2014) Regulatory considerations in production of a cell therapy medicinal product in Europe to clinical research. Clin. Exp. Med. 14, 25-33 CrossRef PubMed